Buys | $0 | 0 | 0 |
Sells | $12,453 | 2 | 100 |
BORGESON JOHN A. | See Remarks | 0 | $0 | 2 | $12,453 | $-12,453 |
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate …
Over the last 12 months, insiders at Kodiak Sciences Inc. have bought $0 and sold $12,453 worth of Kodiak Sciences Inc. stock.
On average, over the past 5 years, insiders at Kodiak Sciences Inc. have bought $114.81M and sold $7.31M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 13,155 shares for transaction amount of $104,363 was made by BAKER FELIX () on 2022‑06‑02.
2024-06-17 | Sale | BORGESON JOHN A. | See Remarks | 2,874 0.0053% | $2.75 | $7,904 | +35.69% | |
2024-06-12 | Sale | BORGESON JOHN A. | See Remarks | 1,558 0.0031% | $2.92 | $4,549 | +30.65% | |
2023-06-16 | Sale | BORGESON JOHN A. | See Remarks | 2,749 0.0054% | $9.23 | $25,373 | -64.78% | |
2023-06-16 | Sale | EHRLICH JASON | See Remarks | 2,258 0.0044% | $9.23 | $20,841 | -64.78% | |
2023-06-14 | Sale | BORGESON JOHN A. | See Remarks | 1,448 0.0029% | $9.42 | $13,640 | -64.84% | |
2023-06-14 | Sale | EHRLICH JASON | See Remarks | 1,132 0.0023% | $9.42 | $10,663 | -64.84% | |
2022-06-15 | Sale | BORGESON JOHN A. | See Remarks | 2,798 0.0053% | $7.02 | $19,642 | +3.65% | |
2022-06-15 | Sale | EHRLICH JASON | See Remarks | 2,282 0.0043% | $7.02 | $16,020 | +3.65% | |
2022-06-02 | BAKER FELIX | 13,155 0.0255% | $7.93 | $104,363 | -6.75% | |||
2022-05-25 | BAKER FELIX | 116 0.0002% | $6.75 | $784 | +10.48% | |||
2022-05-16 | BAKER FELIX | 8,118 0.0163% | $5.99 | $48,599 | +29.47% | |||
2022-02-25 | Sale | PERLROTH VICTOR | Chairman and CEO | 340,000 0.6641% | $8.99 | $3.06M | -12.81% | |
2022-02-24 | Sale | PERLROTH VICTOR | Chairman and CEO | 1M 1.9233% | $9.20 | $9.2M | -16.03% | |
2022-02-17 | BAKER BROS. ADVISORS LP | 300,000 0.5801% | $54.56 | $16.37M | -28.56% | |||
2022-02-16 | BAKER BROS. ADVISORS LP | 95,165 0.1782% | $54.12 | $5.15M | -30.14% | |||
2022-02-15 | BAKER BROS. ADVISORS LP | 5,800 0.0107% | $54.16 | $314,099 | -31.11% | |||
2022-01-31 | BAKER BROS. ADVISORS LP | 30,148 0.0563% | $57.22 | $1.73M | -32.88% | |||
2022-01-28 | BAKER BROS. ADVISORS LP | 55,258 0.0977% | $50.42 | $2.79M | -27.90% | |||
2022-01-27 | BAKER BROS. ADVISORS LP | 262,259 0.5015% | $51.76 | $13.57M | -24.08% | |||
2022-01-25 | BAKER BROS. ADVISORS LP | 5,500 0.0104% | $58.90 | $323,934 | -34.11% |
BAKER FELIX | 15617369 29.6774% | $56.85M | 3 | 0 | +11.07% | |
BAKER BROS. ADVISORS LP | 14734965 28.0006% | $53.64M | 41 | 0 | +11.65% | |
PROFUSEK ROBERT | director | 10000 0.019% | $36,400.00 | 1 | 0 | <0.0001% |
Levy Richard S | director | 1000 0.0019% | $3,640.00 | 1 | 0 | +41% |
$7,150,333 | 87 | -8.28% | $207.01M | |
Kodiak Sciences Inc. (KOD) | $613,304,943 | 46 | 11.85% | $191.55M |
$48,218,096 | 42 | 0.89% | $204.72M | |
$63,049,419 | 31 | 2.87% | $207.33M | |
$41,069,367 | 23 | 54.64% | $211.17M |
Increased Positions | 53 | +47.75% | 6M | +16.4% |
Decreased Positions | 44 | -39.64% | 4M | -9.78% |
New Positions | 22 | New | 3M | New |
Sold Out Positions | 14 | Sold Out | 2M | Sold Out |
Total Postitions | 120 | +8.11% | 42M | +6.62% |
Baker Bros. Advisors Lp | $71,146.00 | 32.66% | 17.31M | 0 | 0% | 2024-12-31 |
Blackrock, Inc. | $15,320.00 | 7.03% | 3.73M | -210,401 | -5.34% | 2024-12-31 |
Vanguard Group Inc | $6,914.00 | 3.17% | 1.68M | -2,920 | -0.17% | 2024-12-31 |
Acadian Asset Management Llc | $6,298.00 | 2.89% | 1.53M | -421,885 | -21.59% | 2024-12-31 |
Price T Rowe Associates Inc /Md/ | $5,214.00 | 2.39% | 1.27M | +1M | +10,982.55% | 2024-12-31 |
Tcg Crossover Management, Llc | $4,708.00 | 2.16% | 1.15M | +137,380 | +13.63% | 2024-12-31 |
Adage Capital Partners Gp, L.L.C. | $4,683.00 | 2.15% | 1.14M | +1M | New | 2024-12-31 |
Iconiq Capital, Llc | $4,179.00 | 1.92% | 1.02M | 0 | 0% | 2024-12-31 |
Boxer Capital Management, Llc | $4,110.00 | 1.89% | 1M | +1M | New | 2024-12-31 |
Silverarc Capital Management, Llc | $4,110.00 | 1.89% | 1M | +500,000 | New | 2024-12-31 |